{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:17:51Z","timestamp":1794071871747,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.diabres.2022.109977","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T20:02:33Z","timestamp":1656360153000},"page":"109977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["One-hour post-load glucose is associated with severity of hepatic fibrosis risk"],"prefix":"10.1016","volume":"189","author":[{"given":"Ram","family":"Jagannathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Vanessa","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.109977_b0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","article-title":"Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action","volume":"40","author":"Bril","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109977_b0010","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, Qiu Y, Burns L, Afendy A and Nader FJJoh. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. 2019;71:793-801.","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"10.1016\/j.diabres.2022.109977_b0015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/dc10-2229","article-title":"Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study","volume":"34","author":"Williamson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109977_b0020","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109977_b0025","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.diabres.2022.109977_b0030","doi-asserted-by":"crossref","unstructured":"Bergman M, Manco M, Sesti G, Dankner R, Pareek M, Jagannathan R, Chetrit A, Abdul-Ghani M, Buysschaert M, Olsen MHJDr and practice c. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose\u2265 155 mg\/dl (8.6 mmol\/L). 2018;146:18-33.","DOI":"10.1016\/j.diabres.2018.09.017"},{"key":"10.1016\/j.diabres.2022.109977_b0035","article-title":"Chung SJDr and practice c","volume":"165","author":"Bergman","year":"2020","journal-title":"Review of methods for detecting glycemic disorders"},{"key":"10.1016\/j.diabres.2022.109977_b0040","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1210\/jc.2018-00468","article-title":"One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes","volume":"103","author":"Fiorentino","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.109977_b0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.numecd.2011.02.002","article-title":"One-hour post-load plasma glucose levels are associated with elevated liver enzymes","volume":"21","author":"Succurro","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2022.109977_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000016","article-title":"Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease","volume":"2","author":"Sesti","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2022.109977_b0055","doi-asserted-by":"crossref","unstructured":"Sesti G, Hribal ML, Fiorentino TV, Sciacqua A, Perticone FJBODR and Care. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. 2014;2:e000016.","DOI":"10.1136\/bmjdrc-2014-000016"},{"key":"10.1016\/j.diabres.2022.109977_b0060","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2016-1856","article-title":"One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects","volume":"101","author":"Fiorentino","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.109977_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.diabres.2022.109977_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd22-as01","article-title":"Standards of Medical Care in Diabetes\u20142022 Abridged for Primary Care Providers","volume":"40","author":"American","year":"2022","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.diabres.2022.109977_b0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109977_b0080","doi-asserted-by":"crossref","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM and Sanyal AJJH. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. 2018;67:328-357.","DOI":"10.1002\/hep.29367"},{"key":"10.1016\/j.diabres.2022.109977_b0085","doi-asserted-by":"crossref","unstructured":"Roh YH, Kang B-K, Jun DW, Lee C-m and Kim M. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center. Scientific Reports. 2021;11:13616.","DOI":"10.1038\/s41598-021-93038-6"},{"key":"10.1016\/j.diabres.2022.109977_b0090","article-title":"One-Hour Postload Plasma Glucose in Obese Indian Adults with Nonalcoholic Fatty Liver Disease: An Observational Study from North India","volume":"25","author":"Jesrani","year":"2021","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.109977_b0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.numecd.2013.11.005","article-title":"Dietary patterns and 1-h post-load glucose in essential hypertension","volume":"24","author":"Sciacqua","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2022.109977_b0100","first-page":"2180","article-title":"Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450\u20132E1\u2013Mediated Oxidative and Nitrative","volume":"73","author":"Cho","year":"2021","journal-title":"Stress"},{"key":"10.1016\/j.diabres.2022.109977_b0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm4074","article-title":"Transcriptional regulation of hepatic lipogenesis","volume":"16","author":"Wang","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.diabres.2022.109977_b0110","article-title":"Association of oxidative stress biomarkers with gestational diabetes mellitus in pregnant women: a case-control study","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2022.109977_b0115","doi-asserted-by":"crossref","unstructured":"Hashiba M, Ono M, Hyogo H, Ikeda Y, Masuda K, Yoshioka R, Ishikawa Y, Nagata Y, Munekage K and Ochi TJPO. Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. 2013;8:e76161.","DOI":"10.1371\/journal.pone.0076161"},{"key":"10.1016\/j.diabres.2022.109977_b0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2022.109977_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195028","article-title":"Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring","volume":"13","author":"Honda","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2022.109977_b0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","article-title":"Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients","volume":"30","author":"Kim","year":"2010","journal-title":"Liver international : official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.diabres.2022.109977_b0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5114\/ceh.2021.104543","article-title":"FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study","volume":"7","author":"Catanzaro","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.diabres.2022.109977_b0140","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association."},{"key":"10.1016\/j.diabres.2022.109977_b0145","doi-asserted-by":"crossref","unstructured":"Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G and Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel, Switzerland). 2021;11.","DOI":"10.3390\/diagnostics11010098"},{"key":"10.1016\/j.diabres.2022.109977_b0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2036.2010.04500.x","article-title":"Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C","volume":"33","author":"Martinez","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.diabres.2022.109977_b0155","first-page":"454","article-title":"The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? Journal of the Formosan Medical Association =","volume":"121","author":"Xu","year":"2022","journal-title":"Taiwan yi zhi."},{"key":"10.1016\/j.diabres.2022.109977_b0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2022.109977_b0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"10.1016\/j.diabres.2022.109977_b0170","doi-asserted-by":"crossref","unstructured":"Bergman M, Manco M, Sesti G, Dankner R, Pareek M, Jagannathan R, Chetrit A, Abdul-Ghani M, Buysschaert M, Olsen MHJDr and practice c. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose\u2265 155 mg\/dl (8.6 mmol\/L). 2018.","DOI":"10.1016\/j.diabres.2018.09.017"},{"key":"10.1016\/j.diabres.2022.109977_b0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc19-1071","article-title":"Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes","volume":"43","author":"Bril","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109977_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108882","article-title":"Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study","volume":"177","author":"Besutti","year":"2021","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722007914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722007914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:24:12Z","timestamp":1759173852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722007914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"alternative-id":["S0168822722007914"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109977","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-hour post-load glucose is associated with severity of hepatic fibrosis risk","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109977"}}